Literature DB >> 30377134

[Overpression of miR-29b suppresses the proliferation and induces apoptosis of cholangiocarcinoma cells].

Kun Cao1, Liangquan Sun2, Yewei Zhang2, Tengfei Wang2, Haiyang Li2, Shi Zuo2.   

Abstract

OBJECTIVE: To investigate the expression of miR-29b in cholangiocarcinoma and explore its effects on cell proliferation and apoptosis of cholangiocarcinoma cells.
METHODS: Real-time PCR was used to detect the expression of miR-29b in cholangiocarcinoma cells line QBC939 and cholangiocarcinoma tissues. The lentiviral vector LV-hsa-miR-29b and blank vector were constructed to infect QBC939 cells. MTT assay and cell clone formation assay were performed to assess the changes in the cell proliferation and clone formation, respectively; flow cytometry was employed to evaluate the effect of miR-29b overexpression on cell cycle and apoptosis.
RESULTS: The expression of miR-29b was significantly down-regulated in QBC939 cells and cholangiocarcinoma tissues as compared with H-69 cells and normal tissues (P < 0.01). Compared with the blank vector, the lentiviral vector LV-hsa-miR-29b caused significantly increased expression of miR-29b in QBC939 cells (P < 0.01), which exhibited suppressed cell proliferation and clone formation (P < 0.01 or 0.05), cell cycle arrest at the S phase (P < 0.05), and significantly increased cell apoptosis (P < 0.01).
CONCLUSIONS: As a tumor-suppressing miRNA, miR-29b is down-regulated in cholangiocarcinoma, and its overexpression can suppress the proliferation and induce apoptosis of cholangiocarcinoma cells.

Entities:  

Keywords:  apoptosis; cholangiocarcinoma; miR-29b; proliferation

Mesh:

Substances:

Year:  2018        PMID: 30377134      PMCID: PMC6744069          DOI: 10.3969/j.issn.1673-4254.2018.10.13

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  29 in total

1.  Silencing of microRNAs in vivo with 'antagomirs'.

Authors:  Jan Krützfeldt; Nikolaus Rajewsky; Ravi Braich; Kallanthottathil G Rajeev; Thomas Tuschl; Muthiah Manoharan; Markus Stoffel
Journal:  Nature       Date:  2005-10-30       Impact factor: 49.962

Review 2.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

Authors:  Witold Filipowicz; Suvendra N Bhattacharyya; Nahum Sonenberg
Journal:  Nat Rev Genet       Date:  2008-02       Impact factor: 53.242

3.  RUNX3-mediated up-regulation of miR-29b suppresses the proliferation and migration of gastric cancer cells by targeting KDM2A.

Authors:  Ye Kong; Shuiyan Zou; Fenghua Yang; Xia Xu; Wenhong Bu; Jihui Jia; Zhifang Liu
Journal:  Cancer Lett       Date:  2016-08-03       Impact factor: 8.679

4.  mir-29 regulates Mcl-1 protein expression and apoptosis.

Authors:  J L Mott; S Kobayashi; S F Bronk; G J Gores
Journal:  Oncogene       Date:  2007-04-02       Impact factor: 9.867

5.  Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells.

Authors:  Arianna Bellazzo; Giulio Di Minin; Elena Valentino; Daria Sicari; Denis Torre; Luigi Marchionni; Federica Serpi; Michael B Stadler; Daniela Taverna; Gaia Zuccolotto; Isabella Monia Montagner; Antonio Rosato; Federica Tonon; Cristina Zennaro; Chiara Agostinis; Roberta Bulla; Miguel Mano; Giannino Del Sal; Licio Collavin
Journal:  Cell Death Differ       Date:  2018-03-22       Impact factor: 15.828

6.  miR-29b Mediates NF-κB Signaling in KRAS-Induced Non-Small Cell Lung Cancers.

Authors:  Stephanie Langsch; Ulrich Baumgartner; Stefan Haemmig; Cornelia Schlup; Stephan C Schäfer; Sabina Berezowska; Gregor Rieger; Patrick Dorn; Mario P Tschan; Erik Vassella
Journal:  Cancer Res       Date:  2016-05-19       Impact factor: 12.701

Review 7.  Multimodality treatment of intrahepatic cholangiocarcinoma: A review.

Authors:  Kerri A Simo; Laura E Halpin; Nicole M McBrier; Jacob A Hessey; Erin Baker; Samuel Ross; Ryan Z Swan; David A Iannitti; John B Martinie
Journal:  J Surg Oncol       Date:  2016-01       Impact factor: 3.454

8.  lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA.

Authors:  Mengxin Lv; Zhenyu Zhong; Mengge Huang; Qiang Tian; Rong Jiang; Junxia Chen
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-08-02       Impact factor: 4.739

Review 9.  The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets.

Authors:  Dawn Q Chong; Andrew X Zhu
Journal:  Oncotarget       Date:  2016-07-19

Review 10.  The role of miR-29b in cancer: regulation, function, and signaling.

Authors:  Bin Yan; Qiong Guo; Fa-Jun Fu; Zhao Wang; Zhuo Yin; Yong-Bao Wei; Jin-Rui Yang
Journal:  Onco Targets Ther       Date:  2015-03-03       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.